反应详情

The title compound was prepared following the procedure described for Example 94, but starting from 4-(5-(1-(2-fluorophenyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-3-yl)benzaldehyde, obtained as described in Example 113, Step 1, (200 mg; 0.48 mmol) and 1-aminocyclopropanecarboxylic acid (98.1 mg; 0.97 mmol) to give Example 162 as a white solid. 1H NMR: (DMSO-d6, 400 MHz) δ 8.75 (2H, dd, J=4.5, 1.6 Hz), 7.95-7.87 (3H, m), 7.76-7.69 (1H, m), 7.61 (2H, dd, J=4.5, 1.7 Hz), 7.56-7.47 (4H, m), 3.95 (2H, s), 1.18-1.14 (2H, m), 0.96-0.92 (2H, m). LC/MS (Method C): 498 (M+H)+. HPLC (Method F) Rt 2.70 min (Purity: 98.6%).

1. customobtained